July 3, 2024
AI Diagnostics, Private Equity in Your Practice
In This Episode
John Bertrand (CEO, Digital Diagnostics) speaks with us about LumineticsCore, an AI diagnostic system that autonomously diagnoses patients for diabetic retinopathy, including macular edema, to detect disease before it leads to blindness. Also, regular contributor Dr. MedLaw discusses the role of private equity in your practice.
Enjoy Listening!
Changes Are Coming Soon!
Stay tuned for an exciting new format, dropping July 10!
Advertisement
CONTENT CONTINUES BELOW 
John Bertrand
Digital Diagnostics
Co-Founder and Chief Executive Officer
Dr. MedLaw
Advertisement
Explore More Podcast Episodes
Business of Medicine
Advertisement
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
